According to the business intelligence report titled ‘GLOBAL Metagenomics Market 2019-2027’, available with Market Study Report, global metagenomics market is projected to exhibit a CAGR of 15.61% during 2019-2027.
 

Global metagenomics market is largely driven by rising awareness and development of various platforms & devices for DNA sequencing. Also, broadening scope of metagenomics and increasing integration of computing technologies in metagenomic experiments are adding considerable traction to business development.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2515924/
 

Rise in favorable government initiatives in emerging economies, along with advancements in next-gen sequencing processes are expected to open up new growth avenues in the upcoming years. However, certain complexities associated with DNA sequencing methods together with bioinformatics limitations are the major growth barriers for the industry.
 

Based on technology, global metagenomics market is categorized into bioinformatics and sequencing. In terms of application scope, the industry is divided into infectious disease diagnosis, gut microbe characterization, environmental remediation, biotechnology, agriculture, and biofuel. Proceeding further, the product segmentation comprises instruments, consumables, and software.
 

From a geographical perspective, North America, Latin America, Middle East & Africa, Asia Pacific, and Europe are the key contributors to the overall metagenomics industry value. Speaking of country-level fragmentation, United States, Canada, Germany, Italy, France, Spain, United Kingdom, Russia, Japan, India China, South Korea, ASEAN Countries, Australia & New Zealand, Mexico, Brazil, Saudi Arabia, United Arab Emirates, Turkey, and South Africa are the key growth avenues for the industry
 

Experts analysts cite that Asia Pacific market is touted to grow at an exponential rate in the forthcoming years, driven by high prevalence of cancer and other target diseases, increasing healthcare expenditure, and growing investments & funds in R&D. Expanding middle-class population, and rapid rise in elderly population count are further expanding remuneration prospects of the industry in this region, especially in China.
 

Top competitors in global metagenomics industry sphere are Novogene Co., Ltd., GenoScreen, Takara Bio, Inc., Pacific Biosciences of California, Inc., Oxford Nanopore Technologies Ltd., Integragen SA, PerkinElmer, Inc., Illumina, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., F. Hoffmann-La Roche AG, Swift Biosciences, Inc., Enterome SA, Qiagen NV, and Bio-Rad Laboratories, Inc.